Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18133
Title: Global Cardioplegia Practices: Results from the Global Cardiopulmonary Bypass Survey.
Authors: Ali, Jason M;Miles, Lachlan F;Abu-Omar, Yasir;Galhardo, Carlos;Falter, Florian
Affiliation: Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia
Department of Cardiothoracic Surgery, Royal Papworth Hospital, Cambridge, UK
Department of Anesthesiology, National Institute of Cardiology, Rio-de-Janiero, Brazil
Department of Anesthesia, Royal Papworth Hospital, Cambridge, UK
Issue Date: Jun-2018
Citation: The journal of extra-corporeal technology 2018; 50(2): 83-93
Abstract: Despite the ubiquitous use of cardioplegia in cardiac surgery, there is a lack of agreement on various aspects of cardioplegia practice. To discover current cardioplegia practices throughout the world, we undertook a global survey to document contemporary cardiopulmonary bypass practices. A 16-question, Internet-based survey was distributed by regional specialist societies, targeting adult cardiac anesthesiologists. Ten questions concerned caseload and cardioplegia practices, the remaining questions examined anticoagulation and pump-priming practices. The survey was available in English, Spanish, and Portuguese. The survey was launched in June 2015 and remained open until May 2016. A total of 923 responses were analyzed, summarizing practice in Europe (269), North America (334), South America (215), and Australia/New Zealand (105). Inter-regional responses differed for all questions asked (p < .001). In all regions other than South America, blood cardioplegia was the common arrest technique used. The most commonly used cardioplegia solutions were: St. Thomas, Bretschneider, and University of Wisconsin with significant regional variation. The use of additives (most commonly glucose, glutamate, tris-hydroxymethyl aminomethane, and aspartate) varied significantly. This survey has revealed significant variation in international practice with regards to myocardial protection, and is a reminder that there is no clear consensus on the use of cardioplegia. It is unclear why regional practice groups made the choices they have and the clinical impact remains unclear.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18133
PubMed URL: 29921986
ISSN: 0022-1058
Type: Journal Article
Subjects: blood
cardioplegia
cardiopulmonary bypass
crystalloid
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.